Swiss All Share Index
17.290,01
PKT
+50,26
PKT
+0,29
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.10.12 | UBS equal-weight | Morgan Stanley | |
| 26.10.12 | Clariant buy | Vontobel Research | |
| 26.10.12 | Logitech hold | Vontobel Research | |
| 26.10.12 | Novartis reduce | Vontobel Research | |
| 26.10.12 | UBS neutral | Sarasin Research | |
| 26.10.12 | SGS SA buy | Vontobel Research | |
| 25.10.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 25.10.12 | Schindler neutral | Exane-BNP Paribas SA | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 25.10.12 | UBS hold | Vontobel Research | |
| 25.10.12 | Logitech neutral | Sarasin Research | |
| 25.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.10.12 | Novartis reduce | Vontobel Research | |
| 25.10.12 | Logitech hold | Vontobel Research | |
| 25.10.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 24.10.12 | Temenos underperform | Cheuvreux SA | |
| 24.10.12 | Novartis underperform | Cheuvreux SA | |
| 24.10.12 | Temenos equal-weight | Morgan Stanley | |
| 24.10.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 24.10.12 | Temenos buy | Vontobel Research | |
| 24.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 24.10.12 | Sonova buy | Vontobel Research | |
| 24.10.12 | GAM hold | Vontobel Research | |
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 24.10.12 | SGS SA buy | Vontobel Research | |
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 23.10.12 | Swiss Re neutral | Credit Suisse Group | |
| 23.10.12 | Holcim overweight | HSBC | |
| 23.10.12 | Holcim overweight | HSBC | |
| 23.10.12 | Holcim neutral | Credit Suisse Group | |
| 23.10.12 | UBS hold | Commerzbank Corp. & Markets | |
| 23.10.12 | Holcim outperform | Credit Suisse Group | |
| 23.10.12 | Nestlé overweight | J.P. Morgan Cazenove | |
| 23.10.12 | Barry Callebaut underperform | Cheuvreux SA | |
| 23.10.12 | Novartis buy | Nomura | |
| 23.10.12 | Schindler outperform | Cheuvreux SA | |
| 23.10.12 | SGS SA outperform | Cheuvreux SA | |
| 23.10.12 | ams-OSRAM buy | UBS AG |